|
MAML2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.178400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.471240E-01 |
| Normal-vs-Stage2 |
8.113400E-01 |
| Normal-vs-Stage3 |
4.566200E-02 |
| Normal-vs-Stage4 |
3.53650000000094E-05 |
| Stage1-vs-Stage2 |
2.688400E-01 |
| Stage1-vs-Stage3 |
1.758610E-03 |
| Stage1-vs-Stage4 |
5.20049999730432E-08 |
| Stage2-vs-Stage3 |
2.747000E-01 |
| Stage2-vs-Stage4 |
1.532020E-02 |
| Stage3-vs-Stage4 |
5.253800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.414000E-01 |
| Normal-vs-AfricanAmerican |
5.340100E-02 |
| Normal-vs-Asian |
8.793800E-01 |
| Caucasian-vs-AfricanAmerican |
7.951800E-02 |
| Caucasian-vs-Asian |
9.586600E-01 |
| AfricanAmerican-vs-Asian |
5.368600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.382200E-02 |
| Normal-vs-Female |
3.849800E-01 |
| Male-vs-Female |
1.161520E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.635200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.565800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.583970E-01 |
| Normal-vs-Age(81-100Yrs) |
2.751600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.895800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.778000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.278400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.181400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.597800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.014000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.200800E-03 |
| Normal-vs-Grade 2 |
1.375640E-01 |
| Normal-vs-Grade 3 |
1.716020E-01 |
| Normal-vs-Grade 4 |
1.82459999997775E-06 |
| Grade 1-vs-Grade 2 |
2.634200E-02 |
| Grade 1-vs-Grade 3 |
1.258870E-03 |
| Grade 1-vs-Grade 4 |
3.07900000051653E-07 |
| Grade 2-vs-Grade 3 |
5.618900E-03 |
| Grade 2-vs-Grade 4 |
5.83460000314062E-08 |
| Grade 3-vs-Grade 4 |
8.354700E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.51989999999503E-05 |
| Normal-vs-ccB subtype |
1.724850E-03 |
| ccA subtype-vs-ccB subtype |
7.73825448163734E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.567800E-01 |
| Normal-vs-N1 |
2.680200E-02 |
| N0-vs-N1 |
3.463800E-02 |
|
|
